Rates of events such as all-cause death, heart attack, stroke, and hospitalization for chest pain, heart failure, and respiratory infections were comparable.
Trial shows that COVID vaccine doesn’t raise risk of poor outcomes in acute coronary syndrome patients
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows